To Our New Jersey Life Sciences Community:
Welcome to another edition of the Weekender.
New Jersey’s dynamic life sciences ecosystem continues to be a leader with amazing stories and accomplishments making the news this week.
Rutgers Biomedical and Health Sciences Progress Report highlighted a long list of impressive activities, including innovative research studies underway and the merger between the Robert Wood Johnson Health System and Barnabas Health System — forming the largest health system in New Jersey and one of the 10 largest in the U.S.
New Jersey companies once again are represented at the global forefront of developing important drugs to meet significant unmet medical needs, as recognized in recent announcements from BioNJ Members ADMA Biologics, Soligenix and Immunomedics.
BioNJ Member Merck’s Ebola vaccine, developed in tandem with NewLink, has protected 100% of patients from Ebola infection in a novel “ring study.” This is truly a game changer!
BioNJ is looking forward to bringing the industry’s thought leaders together at this year’s 3rd Annual CEO Summit, October 9, where we will be Taking It Over the Top with top-notch programs and speakers, including Dr. Stephen Ostroff, Acting FDA Commissioner.
Click here to read this week’s Weekender.